LONDON (ShareCast) - Clinical research and development group Venn Life Sciences Holdings has confirmed Jonathan Hartshorn has begun his tenure as the group's new chief financial officer.
The London-listed company had appointed Hartshorn, who left his role as head of finance for the onshore division of Mainstream Renewable Power, on 12 May.
"It is important that we maintain a strong focus on the business's financial management and I am confident that Jonathan will be a great asset to the business in this regard," group chief executive Tony Richardson said at the time of the appointment.
Venn shares were down 2.05% to 21.55p at 10:33 on Monday.
Email this article to a friend
or share it with one of these popular networks: